Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;468(12):3393-8.
doi: 10.1007/s11999-010-1583-2. Epub 2010 Sep 24.

Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?

Affiliations

Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?

Yong-Chan Ha et al. Clin Orthop Relat Res. 2010 Dec.

Abstract

Background: Prolonged use of bisphosphonates in patients with osteoporosis reportedly induces femoral insufficiency fractures. However, the natural course of these fractures and how to treat them remain unknown.

Questions/purposes: We determined the rates of fracture displacement and subsequent operations of undisplaced insufficiency fractures of the femur in patients treated with prolonged bisphosphonate therapy.

Patients and methods: We retrospectively collected and reviewed the clinical course of 11 patients (14 fractures) who had been diagnosed as having an insufficiency fracture of the femur after prolonged use (mean, 4.5 years; range, 3-10 years) of bisphosphonate. All patients were women with a mean age of 68 years (range, 57-82 years). The fracture site was subtrochanteric in six and femoral shaft in eight. The minimum followup was 12 months (mean, 27 months; range, 12-60 months).

Results: During the followup period, secondary displacement of the fracture occurred in five of the 14 fractures after a mean of 10 months (range, 1-19 months). Three fractures were treated with internal fixation using a compression hip screw and two with intramedullary nailing. Because five additional fractures were treated surgically owing to intractable pain, surgery was performed in 10 of 14 insufficiency fractures during the followup period. All 10 fractures healed during followup. The remaining four patients (four fractures) not undergoing any surgery had persistent pain.

Conclusions: Femoral insufficiency fractures after prolonged bisphosphonate therapy seldom healed spontaneously and most patients had surgery either for fracture displacement or persistent pain.

PubMed Disclaimer

Figures

Fig. 1A–D
Fig. 1A–D
Patient 4 was a 67-year-old woman who had pain in her right thigh. (A) Her radiograph shows a transverse fracture line and thickening of the lateral cortex at the subtrochanteric area. (B) Her bone scan shows hot uptake at the subtrochanteric area. (C) She experienced a slip after 1 month of followup. Her radiograph shows a completely displaced fracture. She underwent internal fixation using a compression hip screw. (D) Twelve months postoperatively, her radiograph shows complete union of the fracture.
Fig. 2A–D
Fig. 2A–D
Patient 2 was a 64-year-old woman who had pain in her left thigh. (A) Her radiograph shows a transverse fracture line and thickening of the lateral cortex at the subtrochanteric area. (B) At 16 months followup, her radiograph shows progression of the fracture line at the subtrochanteric area. (C) She underwent internal fixation using an intramedullary nail as a result of intractable pain. (D) A radiograph obtained 6 months postoperatively shows complete union of the fracture.

References

    1. Allen MR, Iwata K, Phipps R, Burr DB. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone. 2006;39:872–879. doi: 10.1016/j.bone.2006.04.028. - DOI - PubMed
    1. Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, Papp A, Bauer DC. Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362:1761–1771. doi: 10.1056/NEJMoa1001086. - DOI - PubMed
    1. Boden BP, Osbahr DC, Jimenez C. Low-risk stress fractures. Am J Sports Med. 2001;29:100–111. - PubMed
    1. Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27:687–694. doi: 10.1016/S8756-3282(00)00376-8. - DOI - PubMed
    1. Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA. Alendronate Phase III Osteoporosis Treatment Study Group. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 2004;350:1189–1199. doi: 10.1056/NEJMoa030897. - DOI - PubMed

MeSH terms

Substances